Clinical Trial

Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial

Study acronym: PEACH
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 13, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The "Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery" (PEACH) trial is a study designed to assess the necessity of post-operative antibiotics for preventing surgical site infections (SSIs) in clean-contaminated head and neck surgeries. Recognizing the pivotal role antibiotics have played since their discovery in reducing postoperative infections, this trial aims to determine if a single perioperative antibiotic dose can effectively prevent SSIs, or if additional post-operative antibiotics are required. This study addresses a critical issue in the context of rising antibiotic resistance by potentially limiting unnecessary antibiotic use post-surgery while ensuring patient safety. Results could inform future guidelines, optimizing antibiotic use in surgical prophylaxis and contributing to global efforts against antibiotic resistance.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-11-01; most recent amendment 2024-12-11.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-12-11
Trial Details
NCT Number NCT06672471
Lead Sponsor Shaukat Khanum Memorial Cancer Hospital & Research Centre
Conditions Head and Neck Neoplasms, UADT Neoplasm, Cancer of the Head and Neck, Antibiotic Resistant Infection, Antibiotic Side Effect
Enrollment 170 participants
Start Date 2024-11-15
Primary Completion 2025-08 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2024-12-13